-
Product Insights
Oropharyngeal Cancer Disease - Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Oropharyngeal Cancer Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Oropharyngeal Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Oropharyngeal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Small Intestine Cancer Disease - Global Clinical Trials Review H2 2020
GlobalData's clinical trial report, “Small Intestine Cancer Disease - Global Clinical Trials Review, H2 2020" provides an overview of Small Intestine Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Small Intestine Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor...
-
Product Insights
Vulvar Cancer Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Vulvar Cancer Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Vulvar Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Vulvar Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Hypopharyngeal Cancer Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Hypopharyngeal Cancer Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hypopharyngeal Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypopharyngeal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Sector Analysis
Myelodysplastic Syndrome - Epidemiology Forecast to 2028
MDS are rare and a diverse group of clonal hematopoietic malignancies characterized by cytogenetic and molecular abnormalities, causing bone marrow failure and risk of progression to AML. MDS can affect people of any age but usually is most common in the 70 years and older population, with approximately 86% of newly diagnosed cases in older population over the age of 60 years. MDS patients present with symptoms related to peripheral cytopenias, though they may also be asymptomatic and routine laboratory...
-
Sector Analysis
Acute Myeloid Leukemia - Epidemiology Forecast to 2029
Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow in which the bone marrow produces abnormal red blood cells, white blood cells, or platelets, and generally progresses at a rapid pace. AML is more common in the elderly, is associated with severe complications and high mortality, and accounts for a disproportionately high number of cancer-related deaths. AML is often called acute myelogenous leukemia, acute myeloblastic leukemia, acute granulocytic leukemia, and acute nonlymphocytic leukemia. In 2019, there...
-
Product Insights
Brain Tumor Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Brain Tumor Global Clinical Trials Review, H1, 2020" provides an overview of Brain Tumor Clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Tumor. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Anaplastic Astrocytoma Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020" provides an overview of Anaplastic Astrocytoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Astrocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Brain Cancer Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Brain Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Myelofibrosis Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2020" provides an overview of Myelofibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.